Dr. Lee Ratner, MD
Claim this profileWashington University School of Medicine
Affiliated Hospitals
Washington University School Of Medicine
Washington University
Clinical Trials Lee Ratner, MD is currently running
Smoking Cessation Intervention
for HIV/AIDS
This clinical trial evaluates the usefulness of using a smartphone-based HIV-specific smoking cessation intervention at the time of lung cancer screening in helping people living with HIV quit smoking. Positively Smoke Free - Mobile may help patients with HIV quit smoking.
Recruiting
1 award
N/A
8 criteria
Propranolol
for Kaposi Sarcoma
Kaposi sarcoma (KS) lesions are initiated by endothelial cells infected with KS herpesvirus (KSHV), also known as human herpesvirus 8 (HHV-8). Lesion progression is driven by abnormal angiogenesis, chronic inflammation, and uncontrolled cell proliferation. KS remains one of the most commonly diagnosed cancers in many African countries where economic constraints prevent successful treatment in most patients. Treatment outcomes in developed countries are also often unsatisfactory in HIV positive patients despite good virological and immunological responses to antiretroviral therapy. Therefore, identification of new oral, safe treatment options for treatment of KS remains a research priority. Given the known anti-angiogenic properties and based on the treatment response with other benign vascular lesions such as infantile hemangioma, propranolol is a good candidate for the treatment of KS. The hypothesis of this study is that treating patients with Kaposi sarcoma with propranolol will result in an overall response rate (complete response rate plus partial response rate) of at least 45%, and that propranolol will be safe and well tolerated in this patient population.
Recruiting
1 award
Phase 2
6 criteria
More about Lee Ratner, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Lee Ratner, MD has experience with
- Propranolol
- Recombinant EphB4-HSA Fusion Protein
- Smoking Cessation Intervention
- Nicotine Replacement
- Screening Tool
- Non-Interventional Follow-up
Breakdown of trials Lee Ratner, MD has run
Kaposi's Sarcoma
Kaposi Sarcoma
HIV Infection
Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lee Ratner, MD specialize in?
Lee Ratner, MD focuses on Kaposi's Sarcoma and Kaposi Sarcoma. In particular, much of their work with Kaposi's Sarcoma has involved treating patients, or patients who are undergoing treatment.
Is Lee Ratner, MD currently recruiting for clinical trials?
Yes, Lee Ratner, MD is currently recruiting for 4 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Lee Ratner, MD has studied deeply?
Yes, Lee Ratner, MD has studied treatments such as Propranolol, Recombinant EphB4-HSA Fusion Protein, Smoking Cessation Intervention.
What is the best way to schedule an appointment with Lee Ratner, MD?
Apply for one of the trials that Lee Ratner, MD is conducting.
What is the office address of Lee Ratner, MD?
The office of Lee Ratner, MD is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.